insights_auto
Why is BAX up 2,21%?
Dive Deeperchevron_right
BAX:NYSE
Baxter International Inc
24,00 $
arrow_upward
+2,21%(+0,52) 1D
24,10 $
arrow_upward
+0,42% (+0,10)bedtimeAfter hours
Closed: 30 қыр., 16:00:10 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAX...
Open
23,50 $
High
24,10 $
Low
23,36 $
Mkt. cap
12,41 млрд
Avg. vol.
5,96 млн
Volume
0,00
Dividend
0,17%
Quarterly dividend
0,01 $
Ex-dividend date
2026 ж. 28 там.
52-wk high
30,00 $
52-wk low
15,73 $
EPS
-2,07 $
Beta
0,60
Shares outstanding
517,00 млн
No. of employees
38 мың
Open
23,50 $
High
24,10 $
Low
23,36 $
Mkt. cap
12,41 млрд
Avg. vol.
5,96 млн
Volume
0,00
Dividend
0,17%
Quarterly dividend
0,01 $
Ex-dividend date
2026 ж. 28 там.
52-wk high
30,00 $
52-wk low
15,73 $
EPS
-2,07 $
Beta
0,60
Shares outstanding
517,00 млн
No. of employees
38 мың
News stories
From web sources and news partners
AD HOC NEWS
·
17 сағат бұрын
Baxter International stock faces a Q3 EPS estimate cut
Zacks
·
1 күн бұрын
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
AD HOC NEWS
·
2 күн бұрын
Baxter International stock trades above analyst target
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37,5 мың
Founded1931
HeadquartersDeerfield, Иллинойс, Америка Құрама Штаттары
SectorMedical device
Websitebaxter.com